Fujifilm to start phase II clinical trial of Avigan for COVID-19 patients in U.S.

Fujifilm to start phase II clinical trial of Avigan for COVID-19 patients in U.S.

Japan Today

Published

Fujifilm Holdings Corp said it will start phase II clinical trials of its anti-flu drug Avigan for COVID-19 patients in the United States. The trial will enrol about…

Full Article